Designing Contained Commercial ADC Manufacturing: cGMP Facility Scale Up, CQA‑Driven Layout & Single‑Use Solutions - 17th World ADC San Diego

Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Designing Contained Commercial ADC Manufacturing: cGMP Facility Scale Up, CQA‑Driven Layout & Single‑Use Solutions

10:30 am - Monday 12th October 2026

Laying out practical lessons from translating ADC process into contained, commercial cGMP facility design
Contextualizing how ADC CQAs drive room classification, layout, zoning, and material/personnel flows
Exploring approaches to protect operators and contain highly potent payloads and intermediates
Leveraging single‑use and closed‑system solutions for ADC conjugation, purification, and buffer/media management

Speakers:

Nadene Crain

Nadene Crain

Principal Engineer

cGMPnow

Krishna Kishore Komaragiri

Krishna Kishore Komaragiri

Integrated Solutions Sales Manager, Americas

Sartorius